Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Apr 1;116(7):1629-37.
doi: 10.1002/cncr.24879.

Fyn: a novel molecular target in cancer

Affiliations
Review

Fyn: a novel molecular target in cancer

Yoshihito D Saito et al. Cancer. .

Abstract

Fyn is 59-kDa member of the Src family of kinases that is historically associated with T-cell and neuronal signaling in development and normal cellular physiology. Whereas Src has been heavily studied in cancer, less attention has been traditionally awarded to the other Src kinases such as Fyn. Our group has shown that Fyn is particularly upregulated in prostate cancer in contrast to the alternative members of the Src family. This suggests that it may mediate several important processes attributed to Src kinases in prostate cancer and other malignancies. These functions include not only cellular growth and proliferation but also morphogenesis and cellular motility. Together, these suggest a role for Fyn in both progression and metastasis. As several agents in clinical development affect Fyn activation, understanding the role that Fyn plays in cancer is of great importance in oncology. Cancer 2010. (c) 2010 American Cancer Society.

PubMed Disclaimer

Figures

Figure 1
Figure 1
General linear structure of Fyn and the Src-family members.
Figure 2
Figure 2
FYN is mediates signals from cell surface receptors to a number of critical growth and motility pathways.

Similar articles

Cited by

References

    1. Jemal A, et al. Cancer statistics, 2007. CA Cancer J Clin. 2007;57(1):43–66. - PubMed
    1. Boggon TJ, Eck MJ. Structure and regulation of Src family kinases. Oncogene. 2004;23(48):7918–27. - PubMed
    1. Vlahovic G, Crawford J. Activation of tyrosine kinases in cancer. Oncologist. 2003;8(6):531–8. - PubMed
    1. Yeatman TJ. A renaissance for SRC. Nat Rev Cancer. 2004;4(6):470–80. - PubMed
    1. Chang YM, Kung HJ, Evans CP. Nonreceptor tyrosine kinases in prostate cancer. Neoplasia. 2007;9(2):90–100. - PMC - PubMed